Daniels one of health law’s loudest critics
Indiana Gov. Mitch Daniels is fast becoming critic-in-chief of the health reform law.
Indiana Gov. Mitch Daniels is fast becoming critic-in-chief of the health reform law.
The Indianapolis-based health insurer has more individual and small-business customers than its major competitors, increasing
the impact of health reform.
State attorney general says the federal health care law raises serious constitutional questions, including whether Congress
has the authority to enact a mandate that most Americans purchase health insurance.
Lilly’s lobbying spending represents a 36-percent drop from the final quarter of 2008, even though the Congressional debate
over health care reform peaked during the last quarter of 2009.
Deal with unit of Massachusetts-based Thermo Fisher Scientific would keep many of the employees working in same
location.
The Indiana State Medical Licensing Board voted Thursday to revoke the license of Dr. Beverley Edwards, who practiced in Anderson
from the mid-1980s to the early 2000s.
Most employers in central Indiana are just beginning to figure out what the health insurance reform bill will mean for their
businesses. Caterpillar Inc., which employs nearly 1,500 at an engine plant in Lafayette, expects costs to rise about 20 percent.
Conseco Inc. CEO Jim Prieur says it’s time to change the company’s 27-year-old name partly because it’s become better associated
with a sports facility than with the insurer’s products.
With one of the nation’s largest tanning-bed manufacturers and dozens of salons in central Indiana, a 10-percent tax on tanning
could cost the region jobs.
Eli Lilly is interested in assets that may be offered for sale as a result of Sanofi-Aventis SA and Merck & Co.’s plan to
combine their veterinary units.
Carmel-based insurer Conseco Inc. will ask shareholders to approve changing the company’s name to CNO Financial Group,
the company said Thursday morning.
Daniels told members of the Economic Club of Indianapolis that it’s ridiculous for anyone to suggest the nearly $1 trillion
health care overhaul signed into law Tuesday by President Barack Obama won’t add to the nation’s debt.
Indianapolis-based Eli Lilly and Co. sued rival drugmaker Hospira Inc. to prevent it from selling a generic version of the
cancer drug Gemzar before a patent on the medicine expires in 2013.
Think doctors and hospitals aren’t influenced by money? Think again. Patients seen at private facilities reimbursed
by Medicare were 5.5 times more likely to receive routine cataract surgery than patients at poorly funded Veterans Affairs
facilities.
Attorneys general from 13 states filed suit to stop the overhaul just minutes after the bill signing, contending the law is
unconstitutional. Other state attorneys general may join the lawsuit later or sue separately.
One of the most agreed-upon reasons for health care reform was the expensive overuse of the emergency room by uninsured patients.
But two Hoosier ER docs—one conservative, one liberal—say the implementation of ObamaCare will leave that fundamental
problem unresolved.
The new federal health care bill will put 500,000 more Indiana residents on Medicaid and lead to higher state taxes, Gov.
Mitch Daniels said Monday, but a government insurance proponent said it will help families and businesses.
Monday’s decision throws out a $65.2 million patent-infringement verdict won by Ariad for royalties on Lilly’s osteoporosis
drug Evista and sepsis medicine Xigris.
Attorneys general in at least 13 states have signaled they intend to challenge the constitutionality of the legislation in
court.
Sweeping changes phase in slowly for most, but insurers, hospitals, drug companies, employers, workers, medical device makers
and more will eventually feel impact.